Faculty Information - SEKI Yasufumi

■ Published papers

1.	Case report	TSH-binding Inhibiting Immunoglobulin-negative, Thyroid-stimulating Antibody-positive Amiodarone-induced Thyrotoxicosis 2025/07/01
2.	Case report	Subacute thyroiditis during anti-programmed cell death protein 1 antibody therapy: A case report 2025/05
3.	Case report	Hyponatremia due to preserved non-osmotic arginine vasopressin secretion in adipsic diabetes insipidus: a case report with review of literature. 2024/11
4.	Original article	Effect of GH Deficiency Caused by Nonfunctioning Pituitary Masses on Serum C-reactive Protein Levels. 2023/11
5.	Original article	Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus. 2023/10
6.	Original article	Hyperuricemia and the Severity of Coronavirus Disease 2019 in Japan: A Retrospective Cohort Study - An Inseparable Relation with Hypertension and Chronic Kidney Disease 2023
7.	Original article	Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors 2022
8.	Original article	Comparison of the usefulness of the cardio-ankle vascular index and augmentation index as an index of arteriosclerosis in patients with essential hypertension. 2021/12
9.	Original article	Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves’ Disease: A Retrospective Cohort Study 2021/03/06
10.	Original article	Effect of Pretransplant Use of Calcimimetic on Parathyroid Function after Renal Transplantation. 2021
11.	Original article	Characteristics of NAFLD Based on Hypopituitarism. 2020/10
12.	Original article	Comparison of Shortened with Standard Saline Infusion Test for Primary Aldosteronism Diagnostics 2020/05/08
13.	Original article	Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism 2020/04/30
14.	Original article	Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma. 2020/02
15.	Case report	Primary aldosteronism in Klinefelter’s syndrome: two cases 2019/12
16.	Original article	Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism. 2019/12
17.	Case report	ACTH-Dependent Cyclic Cushing Syndrome Triggered by Glucocorticoid Excess Through a Positive-Feedback Mechanism. 2019/05
18.	Original article	Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level. 2018/06
19.	Original article	Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation. 2018/05
20.	Original article	Elevated (Pro)renin Receptor Expression Contributes to Maintaining Aerobic Metabolism in Growth Hormone Deficiency 2018/03
21.	Case report	Hormone-replacement Therapy for Hepatopulmonary Syndrome and NASH Associated with Hypopituitarism. 2018
22.	Original article	Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease. 2018
23.	Original article	Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism. 2017/12
24.	Original article	The relationships between the differences in central blood pressure and brachial blood pressure and other factors in patients with essential hypertension 2017
25.	Review article	Serum soluble (pro)renin receptor levels in patients with essential hypertension. 2014
26.	Original article	Add-on blockade of (pro)renin receptor in imidapril-treated diabetic SHRsp. 2010/06
Display 5 items
Display all(26)

■ Academic conference presentation

1.	Primary adrenal insufficiency due to recurrent episodes of unilateral adrenal infarction （ポスター掲示，一般） 2025/05
2.	Hypertension in middle-aged and menopausal women （口頭，シンポジウム・ワークショップパネル（指名）） 2024/10/14
3.	Weekly Somapacitan Reduces Serum C-reactive Protein Levels in Adult Patients with Growth Hormone Deficiency （ポスター掲示，一般） 2024/06/03
4.	Increased prevalence of uterine myoma in patients with idiopathic hyperaldosteronism （ポスター掲示，一般） 2024/06/01
5.	A decrease in serum CRP levels after somapacitan therapy for adult growth hormone deficiency （口頭，一般） 2024/02/16
6.	Growth hormone secretion and serum high-sensitivity C-reactive protein levels in adult patients with non-functioning pituitary tumors （ポスター掲示，一般） 2023/06/17
7.	A negative association between growth hormone secretion and inflammation in adult patients with non-functioning pituitary mass （ポスター掲示，一般） 2023/05/15
8.	Renoprotective Effect of Aliskiren Monotherapy in Hypertensive Patients with Obesity and Type 2 Diabetes Mellitus （ポスター掲示，一般） 2022/10/15
9.	Increased Serum High-sensitivity C-reactive Protein in Growth Hormone-deficient Patients with Non-functioning Pituitary Tumors （ポスター掲示，一般） 2021/03/20
10.	High-sensitivity C-reactive protein and growth hormone deficiency in patients with non-functioning pituitary tumors （口頭，一般） 2021/02/19
11.	Effects of Body Mass Index and Estimated Glomerular Filtration Rate on Pituitary Function in Patients with Non-functioning Pituitary Tumor （ポスター掲示，一般） 2019/05/19
12.	Effects of Obesity and Renal Function on Pituitary Function Tests in Patients with Nonfunctioning Pituitary Tumor （ポスター掲示，一般） 2019/03/23
13.	Primary Aldosteronism in Klinefelter's Syndrome: Two Cases Report （ポスター掲示，一般） 2018/09/22
14.	Primary Hyperparathyroidism in a Patient with Primary Aldosteronism （ポスター掲示，一般） 2018/09/22
15.	Renoprotective Effect of Direct Renin Inhibitor Monotherapy in Hypertensive Patients with Type 2 Diabetes or Obesity （口頭，一般） 2018/09/14
16.	Serum soluble (pro)renin receptor concentration is correlated with organ dysfunctions in patients with primary aldosteronism （ポスター掲示，一般） 2018/09
17.	(Pro)renin Receptor Contributes to Maintaining Aerobic Metabolism in GH-deficient Adipose Tissue （ポスター掲示，一般） 2018/03/18
18.	An old patient with acromegaly treated with consideration of past history and preventing frailty （口頭，一般） 2018/02/09
19.	(Pro)renin receptor immunohistochemistry in human organs 2016/09
20.	A novel biomarker urinary soluble (pro)renin receptor excretion is associated with urineph 2016/09
21.	Evaluation of Insulin Sensitivity and Secretion in Primary Aldosteronism. (Pro)renin receptor immunohistochemistry in human organs. 2016/09
22.	Relationships between serum soluble (pro)renin receptor levels and endocrine or metabolic factors in patients with essential hypertension. 2015/09
23.	A Circulating Soluble (Pro)Renin Receptor Level and Its Changes with Growth Hormone replacement in Patients with Growth Hormone Deficiency 2014/06/21
24.	Associations between renal function and indices of renin-angiotensin system in patients with essential hypertension 2014/05
25.	Effects of the direct renin inhibitor on renin-angiotensin system in hypertensive patients with chronic kidney disease 2014/05
26.	Clinical implications of the difference in central blood pressure and brachial blood pressure in patients with essential hypertension 2014/04
27.	CVD therapy for unresectable pheochromocytoma （ポスター掲示，一般） 2013/08
28.	Periodic ectopic Cushing's syndrome potentially evoked by glucocorticoid excess （ポスター掲示，一般） 2013/06/16
29.	High-dose Cabergoline Treatment of Childhood- and Adolescence-onset Prolactinomas. （口頭，一般） 2013/06
Display 5 items
Display all(29)

■ Research areas

Metabolism and endocrinology

■ Awards & honors

1.

2015/03

Endocrine Society Early Career Forum Travel Award

■ Academic society memberships

1.

The Endocrine Society

■ Education

1.	2004/04～2010/03	Faculty of Medicine, Keio University, Graduated,
2.	2012/04～2016/03	〔Doctoral course〕〔Doctorial Course〕, Graduate School, Division of Medicine, Tokyo Women's Medical University, Completed,

■ Academic & professional experience

1.

2025/03～

Assistant Professor

■ External Researcher ID

orcID

https://orcid.org/0000-0002-1950-7704